Registry trials have started to become much more popular today. Traditionally, we are used to randomized controlled trials. While they have been doing their job just fine, they do have limitations. These include a high chance of failure, restricted validity, and of course, the staggeringly high costs associated with it. In light of this, another method has surfaced in popularity due to its apparent cost-effectiveness.
What is this new method and is it really cost-effective?
Registry Based Trials
While traditional trials maintain their position in clinical care, registry-based trials have recently come to the forefront. A registry oriented randomized controlled trial (RRCT) works in a way that the treatment and data outcome is recorded in an existing patient registry.
The interesting thing about registry programs is that they have been recognized as a potential cost-cutting model. In order to identify whether this is actually true, a practical tool and study has emerged to recognize the cost differences between the two options we currently have: the standard clinical trials against the registry-based trials.
Registry Based Trials vs. Standard Clinical Trials: Which is More Cost-Effective?
It was found that registry trials were indeed more cost-effective as compared to standard clinical study at least 98.6 % of the time. In fact, it was found that the savings between the options amounted to a considerable range between $4300 and $600,000.
This paves the way for registry type trials instead of the standard clinical trials that have been used since ages. Now that we have established RRCTs as being more cost-effective, let’s see what they are best suited for.
What Can RRCTs Be Used For? Are There Any Challenges?
RRCTs have a lot of scope in pharmaceutical interventions. The biggest benefit of RRCTs is to analyze the relative effectiveness of treatments in a real-world setting. But this does not mean that registry trials don’t have any challenges.
These issues primarily center on data quality as well as ethical issues. These aren’t major concerns if tackled effectively. The fact is that registry studies are still a relatively new clinical trial methodology, and there is a need to reach a consensus on such issues if you want to be successful.
But despite all these obstacles that need to be overcome, the importance of registry studies, especially when it comes to cost, cannot be undermined. Registries are imperative tools for investigators and have the ability to make beneficial advancements in the healthcare industry without going over the budget.
Registry based trials have broad incorporation. Due to this, they have immense scope in the scientific community to bring about changes that actually matter. In this guide, we helped explore how registry trials are more cost-effective than standard trials and how they help cut down costs incurred during the initial stages of clinical investigation. Once you get your hands on the right software, you will notice there is sufficient room for potential cost savings during clinical trials.